Guarantor Non-Guarantor Subsidiary Financial Information Level 3 (Tables)

12 Months Ended

Dec. 31, 2013

Guarantor - Condensed Consolidating Statements of Operations [Abstract]

Condensed Consolidating Balance Sheet [Table Text Block]

MOMENTIVE SPECIALTY CHEMICALS INC.

CONDENSED CONSOLIDATING BALANCE SHEET

DECEMBER 31, 2013

	Momentive Specialty Chemicals Inc.			Subsidiary Issuers		Combined Subsidiary Guarantors			Combined Non-Guarantor Subsidiaries			Eliminations			Consolidated
Assets
Current assets:
Cash and cash equivalents (including restricted cash of $0 and $14, respectively)	$	165		$	5	$	—		$	223		$	—		$	393
Short-term investments	—			—		—			7			—			7
Accounts receivable, net	179			—		—			422			—			601
Intercompany accounts receivable	190			89		—			374			(653		)	—
Intercompany loans receivable	216			—		—			278			(494		)	—
Inventories:
Finished and in-process goods	105			—		—			152			—			257
Raw materials and supplies	38			—		—			65			—			103
Other current assets	27			—		—			45			—			72
Total current assets	920			94		—			1,566			(1,147		)	1,433
Investment in unconsolidated entities	351			—		29			28			(363		)	45
Deferred income taxes	—			—		—			13			—			13
Other long-term assets	31			59		2			42			—			134
Intercompany loans receivable	1,251			3,355		29			4,221			(8,856		)	—
Property and equipment, net	491			—		—			556			—			1,047
Goodwill	52			—		—			60			—			112
Other intangible assets, net	47			—		—			35			—			82
Total assets	$	3,143		$	3,508	$	60		$	6,521		$	(10,366	)	$	2,866
Liabilities and (Deficit) Equity
Current liabilities:
Accounts payable	$	165		$	—	$	—		$	318		$	—		$	483
Intercompany accounts payable	130			—		—			523			(653		)	—
Debt payable within one year	20			—		—			89			—			109
Intercompany loans payable within one year	173			—		—			321			(494		)	—
Interest payable	10			72		—			1			—			83
Income taxes payable	4			—		—			8			—			12
Accrued payroll and incentive compensation	19			—		—			28			—			47
Other current liabilities	65			—		—			62			—			127
Total current liabilities	586			72		—			1,350			(1,147		)	861
Long-term liabilities:
Long-term debt	309			3,326		—			30			—			3,665
Intercompany loans payable	3,388			—		7			5,461			(8,856		)	—
Accumulated losses of unconsolidated subsidiaries in excess of investment	773			—		261			—			(1,034		)	—
Long-term pension and post employment benefit obligations	50			—		—			184			—			234
Deferred income taxes	8			2		—			15			—			25
Other long-term liabilities	110			6		—			47			—			163
Total liabilities	5,224			3,406		268			7,087			(11,037		)	4,948
Total Momentive Specialty Chemicals Inc. shareholder’s (deficit) equity	(2,081		)	102		(208		)	(565		)	671			(2,081		)
Noncontrolling interest	—			—		—			(1		)	—			(1		)
Total (deficit) equity	(2,081		)	102		(208		)	(566		)	671			(2,082		)
Total liabilities and (deficit) equity	$	3,143		$	3,508	$	60		$	6,521		$	(10,366	)	$	2,866

MOMENTIVE SPECIALTY CHEMICALS INC.

CONDENSED CONSOLIDATING BALANCE SHEET

DECEMBER 31, 2012

	Momentive Specialty Chemicals Inc.			Subsidiary Issuers		Combined Subsidiary Guarantors			Combined Non-Guarantor Subsidiaries			Eliminations			Consolidated
Assets
Current assets:
Cash and cash equivalents (including restricted cash of $0 and $18, respectively)	$	276		$	—	$	—		$	143		$	—		$	419
Short-term investments	—			—		—			5			—			5
Accounts receivable, net	177			—		—			350			—			527
Intercompany accounts receivable	126			52		—			318			(496		)	—
Intercompany loans receivable	162			—		—			624			(786		)	—
Inventories:
Finished and in-process goods	109			—		—			153			—			262
Raw materials and supplies	35			—		—			70			—			105
Other current assets	38			—		—			43			—			81
Total current assets	923			52		—			1,706			(1,282		)	1,399
Investment in unconsolidated entities	252			—		42			18			(270		)	42
Deferred income taxes	337			—		—			23			—			360
Other long-term assets	—			42		28			39			—			109
Intercompany loans receivable	773			2,273		27			3,835			(6,908		)	—
Property and equipment, net	493			—		—			674			—			1,167
Goodwill	93			—		—			76			—			169
Other intangible assets, net	53			—		—			38			—			91
Total assets	$	2,924		$	2,367	$	97		$	6,409		$	(8,460	)	$	3,337
Liabilities and (Deficit) Equity
Current liabilities:
Accounts payable	$	136		$	—	$	—		$	282		$	—		$	418
Intercompany accounts payable	96			4		1			395			(496		)	—
Debt payable within one year	13			—		—			63			—			76
Intercompany loans payable within one year	197			—		—			589			(786		)	—
Affiliated debt payable within one year	—			—		—			—			—			—
Interest payable	12			51		—			—			—			63
Income taxes payable	3			—		—			1			—			4
Accrued payroll and incentive compensation	14			—		—			26			—			40
Other current liabilities	64			—		—			65			—			129
Total current liabilities	535			55		1			1,421			(1,282		)	730
Long-term liabilities:
Long-term debt	860			2,138		—			421			—			3,419
Intercompany loans payable	2,303			4		7			4,594			(6,908		)	—
Accumulated losses of unconsolidated subsidiaries in excess of investment	325			—		107			—			(432		)	—
Long-term pension and post employment benefit obligations	98			—		—			211			—			309
Deferred income taxes	—			1		—			17			—			18
Other long-term liabilities	101			6		—			52			—			159
Advance from affiliates	—			—		—			—			—			—
Total liabilities	4,222			2,204		115			6,716			(8,622		)	4,635
Total (deficit) equity	(1,298		)	163		(18		)	(307		)	162			(1,298		)
Total liabilities and (deficit) equity	$	2,924		$	2,367	$	97		$	6,409		$	(8,460	)	$	3,337

Condensed Consolidating Statement of Operations [Table Text Block]

MOMENTIVE SPECIALTY CHEMICALS INC.

CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS

YEAR ENDED DECEMBER 31, 2013

	Momentive Specialty Chemicals Inc.			Subsidiary Issuers			Combined Subsidiary Guarantors			Combined Non-Guarantor Subsidiaries			Eliminations			Consolidated
Net sales	$	2,176		$	—		$	—		$	2,919		$	(205	)	$	4,890
Cost of sales	1,876			—			—			2,645			(205		)	4,316
Gross profit	300			—			—			274			—			574
Selling, general and administrative expense	108			—			—			254			—			362
Asset impairments	53			—			—			128			—			181
Business realignment costs	12			—			—			9			—			21
Other operating expense (income), net	3			(4		)	(1		)	3			—			1
Operating income	124			4			1			(120		)	—			9
Interest expense, net	34			262			—			7			—			303
Intercompany interest expense (income), net	163			(266		)	(1		)	104			—			—
Loss on extinguishment of debt	4			—			—			2			—			6
Other non-operating (income) expense, net	(30		)	(15		)	—			47			—			2
(Loss) income before income tax, (losses) earnings from unconsolidated entities	(47		)	23			2			(280		)	—			(302		)
Income tax expense	345			1			—			3			—			349
(Loss) income before (losses) earnings from unconsolidated entities	(392		)	22			2			(283		)	—			(651		)
(Losses) earnings from unconsolidated entities, net of taxes	(241		)	—			(170		)	4			424			17
Net (loss) income	(633		)	22			(168		)	(279		)	424			(634		)
Net loss attributable to noncontrolling interest	—			—			—			1			—			1
Net (loss) income attributable to Momentive Specialty Chemicals Inc.	$	(633	)	$	22		$	(168	)	$	(278	)	$	424		$	(633	)
Comprehensive (loss) income attributable to Momentive Specialty Chemicals Inc.	$	(577	)	$	(121	)	$	(44	)	$	(128	)	$	293		$	(577	)

MOMENTIVE SPECIALTY CHEMICALS INC.

CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS

YEAR ENDED DECEMBER 31, 2012

	Momentive Specialty Chemicals Inc.			Subsidiary Issuers			Combined Subsidiary Guarantors			Combined Non-Guarantor Subsidiaries			Eliminations			Consolidated
Net sales	$	2,120		$	—		$	—		$	2,902		$	(266	)	$	4,756
Cost of sales	1,800			—			—			2,626			(266		)	4,160
Gross profit	320			—			—			276			—			596
Selling, general and administrative expense	61			—			—			261			—			322
Asset impairments	—			—			—			23			—			23
Business realignment costs	9			—			—			26			—			35
Other operating expense (income), net	6			2			(1		)	4			—			11
Operating income (loss)	244			(2		)	1			(38		)	—			205
Interest expense, net	59			176			—			28			—			263
Intercompany interest expense (income), net	132			(186		)	(1		)	55			—			—
Other non-operating (income) expense, net	(8		)	(2		)	—			9			—			(1		)
Income (loss) before income tax, (losses) earnings from unconsolidated entities	61			10			2			(130		)	—			(57		)
Income tax benefit	(371		)	—			—			(13		)	—			(384		)
Income (loss) before (losses) earnings from unconsolidated entities	432			10			2			(117		)	—			327
(Losses) earnings from unconsolidated entities, net of taxes	(86		)	—			(71		)	3			173			19
Net income (loss)	$	346		$	10		$	(69	)	$	(114	)	$	173		$	346
Comprehensive income (loss) attributable to Momentive Specialty Chemicals Inc.	$	252		$	13		$	(69	)	$	(207	)	$	263		$	252

MOMENTIVE SPECIALTY CHEMICALS INC.

CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS

YEAR ENDED DECEMBER 31, 2011

	Momentive Specialty Chemicals Inc.			Subsidiary Issuers			Combined Subsidiary Guarantors			Combined Non-Guarantor Subsidiaries			Eliminations			Consolidated
Net sales	$	2,246		$	—		$	—		$	3,254		$	(293	)	$	5,207
Cost of sales	1,856			—			—			2,910			(293		)	4,473
Gross profit	390			—			—			344			—			734
Selling, general and administrative expense	110			—			—			225			—			335
Asset impairments	4			—			—			28			—			32
Business realignment costs	2			—			—			13			—			15
Other operating (income) expense, net	(20		)	—			(1		)	6			—			(15		)
Operating income	294			—			1			72			—			367
Interest expense, net	69			150			—			43			—			262
Intercompany interest expense (income), net	121			(170		)	(1		)	50			—			—
Other non-operating expense (income), net	8			—			—			(5		)	—			3
Income (loss) from continuing operations before income tax, earnings from unconsolidated entities	96			20			2			(16		)	—			102
Income tax (benefit) expense	(8		)	1			—			10			—			3
Income (loss) from continuing operations before earnings from unconsolidated entities	104			19			2			(26		)	—			99
Earnings from unconsolidated entities, net of taxes	31			—			22			1			(38		)	16
Net income (loss) from continuing operations	135			19			24			(25		)	(38		)	115
Net (loss) income from discontinued operations, net of tax	(18		)	—			—			20			—			2
Net income (loss)	$	117		$	19		$	24		$	(5	)	$	(38	)	$	117
Comprehensive income (loss) attributable to Momentive Specialty Chemicals Inc.	$	46		$	20		$	23		$	(20	)	$	(23	)	$	46

Condensed Consolidating Statement of Cash Flows [Table Text Block]

MOMENTIVE SPECIALTY CHEMICALS INC.

CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS

YEAR ENDED DECEMBER 31, 2013

	Momentive Specialty Chemicals Inc.			Subsidiary Issuers			Combined Subsidiary Guarantors			Combined Non-Guarantor Subsidiaries			Eliminations			Consolidated
Cash flows (used in) provided by operating activities	$	(95	)	$	5		$	23		$	251		$	(104	)	$	80
Cash flows provided by (used in) investing activities
Capital expenditures	(75		)	—			—			(69		)	—			(144		)
Capitalized interest	—			—			—			(1		)	—			(1		)
Purchase of debt securities, net	—			—			—			(3		)	—			(3		)
Change in restricted cash	—			—			—			4			—			4
Funds remitted to unconsolidated affiliates, net	—			—			—			(13		)	—			(13		)
Proceeds from sale of assets	—			—			—			7			—			7
Capital contribution to subsidiary	(31		)	—			(20		)	—			51			—
Return of capital from subsidiary	48			—			31			—			(79		)	—
Return of capital from subsidiary from sales of accounts receivable	214			—			—			—			(214		)	—
	156			—			11			(75		)	(242		)	(150		)
Cash flows (used in) provided by financing activities
Net short-term debt borrowings	—			—			—			15			—			15
Borrowings of long-term debt	—			1,109			—			26			—			1,135
Repayments of long-term debt	(545		)	(120		)	—			(393		)	—			(1,058		)
Net intercompany loan borrowings (repayments)	389			(882		)	(2		)	495			—			—
Capital contribution from parent	—			—			20			31			(51		)	—
Long-term debt and credit facility financing fees	(16		)	(24		)	—			—			—			(40		)
Common stock dividends paid	—			(83		)	(21		)	—			104			—
Return of capital to parent	—			—			(31		)	(48		)	79			—
Return of capital to parent from sales of accounts receivable	—			—			—			(214		)	214			—
	(172		)	—			(34		)	(88		)	346			52
Effect of exchange rates on cash and cash equivalents	—			—			—			(4		)	—			(4		)
(Decrease) increase in cash and cash equivalents	(111		)	5			—			84			—			(22		)
Cash and cash equivalents (unrestricted) at beginning of year	276			—			—			125			—			401
Cash and cash equivalents (unrestricted) at end of year	$	165		$	5		$	—		$	209		$	—		$	379

MOMENTIVE SPECIALTY CHEMICALS INC.

CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS

YEAR ENDED DECEMBER 31, 2012

	Momentive Specialty Chemicals Inc.			Subsidiary Issuers			Combined Subsidiary Guarantors			Combined Non-Guarantor Subsidiaries			Eliminations			Consolidated
Cash flows provided by (used in) operating activities	$	88		$	(59	)	$	16		$	160		$	(28	)	$	177
Cash flows provided by (used in) investing activities
Capital expenditures	(57		)	—			—			(76		)	—			(133		)
Proceeds from sale of debt securities, net	—			—			—			2			—			2
Change in restricted cash	—			—			—			(15		)	—			(15		)
Funds remitted to unconsolidated affiliates, net	—			—			—			(3		)	—			(3		)
Proceeds from sale of assets	9			—			—			2			—			11
Capital contribution to subsidiary	(30		)	—			(19		)	—			49			—
Return of capital from subsidiary from sales of accounts receivable	87			—			—			—			(87		)	—
	9			—			(19		)	(90		)	(38		)	(138		)
Cash flows (used in) provided by financing activities
Net short-term debt repayments	—			—			—			(7		)	—			(7		)
Borrowings of long-term debt	—			450			—			3			—			453
Repayments of long-term debt	(278		)	—			—			(209		)	—			(487		)
Repayment of affiliated debt	(2		)	—			—			—			—			(2		)
Repayment of advance from affiliate	(7		)	—			—			—			—			(7		)
Net intercompany loan borrowings (repayments)	251			(364		)	(3		)	116			—			—
Capital contribution from parent	16			—			19			30			(49		)	16
Long-term debt and credit facility financing fees	(2		)	(12		)	—			—			—			(14		)
Common stock dividends paid	(11		)	(15		)	(13		)	—			28			(11		)
Return of capital to parent from sales of accounts receivable	—			—			—			(87		)	87			—
	(33		)	59			3			(154		)	66			(59		)
Effect of exchange rates on cash and cash equivalents	—			—			—			5			—			5
Increase (decrease) in cash and cash equivalents	64			—			—			(79		)	—			(15		)
Cash and cash equivalents (unrestricted) at beginning of year	212			—			—			204			—			416
Cash and cash equivalents (unrestricted) at end of year	$	276		$	—		$	—		$	125		$	—		$	401

MOMENTIVE SPECIALTY CHEMICALS INC.

CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS

YEAR ENDED DECEMBER 31, 2011

	Momentive Specialty Chemicals Inc.			Subsidiary Issuers			Combined Subsidiary Guarantors			Combined Non-Guarantor Subsidiaries			Eliminations			Consolidated
Cash flows (used in) provided by operating activities	$	(41	)	$	8		$	31		$	198		$	(25	)	$	171
Cash flows provided by (used in) investing activities
Capital expenditures	(74		)	—			—			(65		)	—			(139		)
Capitalized interest	(1		)	—			—			—			—			(1		)
Purchases of debt securities, net	—			—			—			(2		)	—			(2		)
Change in restricted cash	—			—			—			3			—			3
Funds remitted to unconsolidated affiliates, net	—			—			—			(4		)	—			(4		)
Proceeds from sale of business, net of cash transferred	49			—			—			124			—			173
Proceeds from sale of assets	2			—			—			1			—			3
Capital contribution to subsidiary	(11		)	—			(19		)	—			30			—
Return of capital from subsidiary	47			—			—			—			(47		)	—
Return of capital from subsidiary from sales of accounts receivable	69			—			—			—			(69		)	—
	81			—			(19		)	57			(86		)	33
Cash flows provided by (used in) financing activities
Net short-term debt (repayments) borrowings	(7		)	—			—			21			—			14
Borrowings of long-term debt	164			—			—			332			—			496
Repayments of long-term debt	(182		)	—			—			(356		)	—			(538		)
Repayment of advance from affiliate	(80		)	—			—			(20		)	—			(100		)
Net intercompany loan borrowings (repayments)	51			4			—			(55		)	—			—
Capital contribution from parent	189			—			—			30			(30		)	189
Long-term debt and credit facility financing fees	(2		)	—			—			—			—			(2		)
Common stock dividends paid	(2		)	(12		)	(12		)	(1		)	25			(2		)
Return of capital to parent	—			—			—			(47		)	47			—
Return of capital to parent from sales of accounts receivable	—			—			—			(69		)	69			—
	131			(8		)	(12		)	(165		)	111			57
Effect of exchange rates on cash and cash equivalents	—			—			—			(5		)	—			(5		)
Increase in cash and cash equivalents	171			—			—			85			—			256
Cash and cash equivalents (unrestricted) at beginning of year	41			—			—			119			—			160
Cash and cash equivalents (unrestricted) at end of year	$	212		$	—		$	—		$	204		$	—		$	416